No phaseRecruiting
A Prospective, Multicenter, Randomized, Parallel-Controlled Superiority Study Evaluating the Efficacy and Safety of a Transcatheter Intramyocardial Septal Radiofrequency Ablation System in Patients With Obstructive Hypertrophic Cardiomyopathy
- Sponsor
- Capital Medical University Affiliated Beijing Anzhen Hospital
- Enrollment
- 82 planned
- Conditions
- Hypertrophic Cardiomyopathy, Obstructive
- Interventions
- Participants in this group will receive a transcatheter intramyocardial septal radiofrequency ablation under intracardiac echocardiography (ICE) guidance using the investigational device system; Participants in this group will undergo a sham procedure under ICE guidance
- Ages
- adults, older adults
- Registry
- ChiCTR2600134002
Full record on the Chinese Clinical Trial RegistrySource: WHO ICTRP, processed October 12, 2026
Primary outcomes
- Treatment Effectiveness Rate at 6 Months;
History
Last registry update
Registered
Started